Hirohiko Ono

802 total citations
13 papers, 150 citations indexed

About

Hirohiko Ono is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Hirohiko Ono has authored 13 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Pathology and Forensic Medicine and 3 papers in Rheumatology. Recurrent topics in Hirohiko Ono's work include Multiple Sclerosis Research Studies (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Hirohiko Ono is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Hirohiko Ono collaborates with scholars based in Japan, United States and Austria. Hirohiko Ono's co-authors include Wakiro Sato, Takashi Yamamura, Shuhei Nishiyama, Hiroshi Kuroda, Yoshiki Takai, Masashi Aoki, Keiko Amano, Tatsuro Misu, Ichiro Nakashima and Mika Watanabe and has published in prestigious journals such as Brain, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Hirohiko Ono

11 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirohiko Ono Japan 6 78 65 36 26 23 13 150
Nathalie Derache France 6 109 1.4× 75 1.2× 23 0.6× 24 0.9× 20 0.9× 18 173
Alessandro Cagol Switzerland 8 142 1.8× 52 0.8× 25 0.7× 20 0.8× 35 1.5× 25 198
Arabella Buchmann Austria 8 69 0.9× 68 1.0× 27 0.8× 13 0.5× 34 1.5× 14 180
Marloes Hagens Netherlands 9 102 1.3× 47 0.7× 19 0.5× 41 1.6× 39 1.7× 10 214
Yee Yen Goh United Kingdom 4 89 1.1× 123 1.9× 66 1.8× 15 0.6× 12 0.5× 8 206
Konstantinos Kilidireas Greece 6 88 1.1× 61 0.9× 22 0.6× 20 0.8× 73 3.2× 8 209
Manuela Matta Italy 8 126 1.6× 45 0.7× 19 0.5× 36 1.4× 30 1.3× 16 203
Luciana Melamud Argentina 8 91 1.2× 63 1.0× 13 0.4× 29 1.1× 71 3.1× 13 172
Carolina Ferreira‐Atuesta United States 3 58 0.7× 57 0.9× 74 2.1× 18 0.7× 31 1.3× 7 204
Stefan Macher Austria 11 52 0.7× 230 3.5× 27 0.8× 13 0.5× 46 2.0× 33 285

Countries citing papers authored by Hirohiko Ono

Since Specialization
Citations

This map shows the geographic impact of Hirohiko Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohiko Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohiko Ono more than expected).

Fields of papers citing papers by Hirohiko Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohiko Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohiko Ono. The network helps show where Hirohiko Ono may publish in the future.

Co-authorship network of co-authors of Hirohiko Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohiko Ono. A scholar is included among the top collaborators of Hirohiko Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohiko Ono. Hirohiko Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ono, Hirohiko, Tatsuro Misu, Yuki Matsumoto, et al.. (2025). CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease. International Journal of Molecular Sciences. 26(8). 3606–3606.
2.
Kuroda, Yusuke, et al.. (2024). Eculizumab led to beneficial clinical course in a patient with generalized myasthenia gravis who developed COVID 19-associated pneumonia. Rinsho Shinkeigaku. 64(2). 109–112. 2 indexed citations
3.
Kaneko, Kimihiko, Hiroshi Kuroda, Yuki Matsumoto, et al.. (2024). Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD. Neurology Neuroimmunology & Neuroinflammation. 11(5). e200293–e200293. 7 indexed citations
4.
Misu, Tatsuro, Yuki Matsumoto, Yoshiki Takai, et al.. (2024). The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese. Multiple Sclerosis and Related Disorders. 92. 106176–106176. 4 indexed citations
5.
Misu, Tatsuro, Yuki Matsumoto, Kimihiko Kaneko, et al.. (2023). Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview. Clinical and Experimental Neuroimmunology. 15(1). 6–15.
6.
Sato, Wakiro, Hirohiko Ono, Takaji Matsutani, et al.. (2021). Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behavior and Immunity. 95. 245–255. 25 indexed citations
7.
Takai, Yoshiki, Tatsuro Misu, Hiroyoshi Suzuki, et al.. (2021). Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders. Brain. 144(8). 2401–2415. 53 indexed citations
8.
Kimura, Yukio, Noriko Sato, Miho Ota, et al.. (2018). Brain abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: Evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging. Journal of Magnetic Resonance Imaging. 49(3). 818–824. 20 indexed citations
9.
Araki, M., Youwei Lin, Hirohiko Ono, Wakiro Sato, & Takashi Yamamura. (2018). Application of immunotherapy for neurological manifestations in hypermobile Ehlers–Danlos syndrome. Therapeutic Advances in Neurological Disorders. 11. 1277015334–1277015334. 3 indexed citations
10.
Lin, Youwei, Wakiro Sato, Hirohiko Ono, et al.. (2018). Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis. Neurology Neuroimmunology & Neuroinflammation. 5(3). e456–e456. 10 indexed citations
11.
Ono, Hirohiko, Wakiro Sato, & Takashi Yamamura. (2017). Dysregulation of T and B cells in myalgic encephalomyelitis/chronic fatigue syndrome. Journal of the Neurological Sciences. 381. 899–900. 3 indexed citations
12.
Takai, Yoshiki, Tatsuro Misu, Shuhei Nishiyama, et al.. (2016). Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development. Neurology. 87(19). 2000–2005. 22 indexed citations
13.
Ono, Hirohiko, Naoki Suzuki, Hideki Mizuno, et al.. (2009). Elevated serum aldolase activity in a patient of non-eosinophilic myofasciitis and synovitis with perifascicular atrophy. Rinsho Shinkeigaku. 49(2/3). 119–122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Derache Breakdown of academic impact, for papers by Alessandro Cagol Breakdown of academic impact, for papers by Arabella Buchmann Breakdown of academic impact, for papers by Marloes Hagens Breakdown of academic impact, for papers by Yee Yen Goh Breakdown of academic impact, for papers by Konstantinos Kilidireas Breakdown of academic impact, for papers by Manuela Matta Breakdown of academic impact, for papers by Luciana Melamud Breakdown of academic impact, for papers by Carolina Ferreira‐Atuesta Breakdown of academic impact, for papers by Stefan Macher
Rankless by CCL
2026